Comparison Chart Lineage Cell Therapeutics, Inc.
Stocks
LCTX
US53566P1093
Biotechnology & Medical Research
|
Market Closed -
NYSE
01:30:00 12/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.010 USD | -0.98% |
|
-6.48% | -39.52% |
| 07/08 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 07/08 | Lineage Cell Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -0.98% | -6.48% | -39.52% | -24.63% | -56.28% | 26Cr |  | | |
- Stock Market
- Stocks
- LCTX Stock
- Charts Lineage Cell Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
